Toronto Dominion Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.36M Buy
+60,000
New +$8.4M 0.01% 685
2023
Q4
Sell
-534,900
Closed -$40.1M 1661
2023
Q3
$40.1M Buy
+534,900
New +$41.1M 0.07% 227
2020
Q1
Sell
-73,700
Closed -$4.79M 1325
2019
Q4
$4.79M Hold
73,700
0.01% 639
2019
Q3
$4.67M Sell
73,700
-482,300
-87% -$31.5M 0.01% 662
2019
Q2
$18.8M Buy
556,000
+408,100
+276% +$26.8M 0.04% 299
2019
Q1
$9.62M Buy
147,900
+113,900
+335% +$7.57M 0.02% 516
2018
Q4
$2.13M Buy
+34,000
New +$2.38M ﹤0.01% 768
2018
Q3
Sell
-116,800
Closed -$8.27M 1461
2018
Q2
$8.27M Buy
116,800
+114,000
+4,071% +$8.05M 0.02% 531
2018
Q1
$211K Buy
+2,800
New +$223K ﹤0.01% 1051

Other funds holding GILD

Toronto Dominion Bank's GILD Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Gilead Sciences (GILD) stake by 39% in Q1 2026, selling an estimated $38.4M and leaving 433,696 shares worth $60.4M. The position accounts for 0.09% of the portfolio, ranked #201.

Toronto Dominion Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $123M in Q1 2023. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Toronto Dominion Bank held 433,696 shares of Gilead Sciences worth $60.4M as of Q1 2026.
  • Toronto Dominion Bank sold 274,186 Gilead Sciences shares in Q1 2026, an estimated $38.4M.
  • Gilead Sciences made up 0.09% of Toronto Dominion Bank's portfolio in Q1 2026, its #201 holding.
  • Toronto Dominion Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Gilead Sciences position peaked at $123M in Q1 2023.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.